BiomX's AI Collaboration with Israel Railways Enhances Safety
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
BiomX Inc. shares surged by 21.73% in pre-market trading as the stock crossed above its 5-day SMA.
The significant price increase follows the announcement that BiomX's subsidiary Zorronet has begun implementing AI and machine learning systems for Israel Railways, achieving a 98% success rate in preventing wildlife collisions on tracks. This collaboration not only highlights the effectiveness of the technology but also opens up further opportunities for expansion within the national infrastructure.
This partnership positions BiomX favorably in the infrastructure safety sector, potentially leading to more contracts and collaborations as the demand for advanced safety solutions grows.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHGE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHGE
Wall Street analysts forecast PHGE stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.276
Low
26.00
Averages
26.00
High
26.00
Current: 0.276
Low
26.00
Averages
26.00
High
26.00
About PHGE
BiomX Inc. is a clinical stage product discovery company developing products using both natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases, such as diabetic foot infections, or DFI. Bacteriophage or phage are bacterial, species-specific, strain-limited viruses that infect, amplify and kill the target bacteria and are considered inert to mammalian cells. By utilizing proprietary combinations of naturally occurring phage and creating novel phage using synthetic biology, it develops phage-based therapies intended to address large-market diseases. The Company offers two phage-based product types: Fixed cocktail therapy and Personalized therapy. Its ongoing programs include BX011 and BX211. BX011 is a fixed multi-phage cocktail, for the treatment of DFI associated with Staphylococcus aureus (S. aureus). BX211 is a phage therapy for the treatment of Diabetic Foot Osteomyelitis (DFO) associated with S. aureus.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BiomX to Acquire 60% Stake in Tsoock for $10.4M
- Acquisition Intent: BiomX announced a non-binding letter of intent to acquire a 60% controlling interest in Tsoock Defense Technologies for $10.4 million, aiming to enhance its market position in defense and critical infrastructure sectors.
- Payment Structure: The deal includes an initial payment of $300,000, with the remaining $10.1 million to be paid in four quarterly installments over 12 months, which helps alleviate immediate financial pressure.
- Strategic Importance: Upon completion, the acquisition is expected to add a secure-site execution and systems integration layer to BiomX's growing defense, security, and first-response portfolio, enhancing its ability to apply technologies in real-world operational environments.
- Future Acquisition Option: The letter of intent also includes an option for BiomX to acquire the remaining 40% of Tsoock for $9.2 million within 36 months post-transaction, providing flexibility and strategic opportunities for future expansion.
See More
BiomX Advances AI Systems with Israel Railways Collaboration
- Implementation of Cooperation Agreement: BiomX's wholly-owned subsidiary Zorronet has commenced the installation of AI and ML-powered detection systems on sections of the Israel Railways network, aimed at protecting wildlife and maintaining national infrastructure, with the initial phase covering four segments and plans for further expansion.
- Significant Success Rate: The large-scale pilot conducted over the past year achieved a 98% success rate in keeping large animals off the railway tracks, with zero related collisions during that period, underscoring its importance in safety management.
- Strong Technological Adaptability: The system integrates multiple data sources to detect human and animal approaches to the tracks, triggering alerts and automated responses based on risk assessments, fully meeting the operational requirements of Israel Railways.
- Infrastructure Expansion Opportunities: The opening of a new eastern line by Israel Railways this week further expands the national rail network, creating potential opportunities for future deployments and deeper collaboration, enhancing BiomX's strategic position in infrastructure safety.
See More
BiomX Completes Strategic Transition to Defense Sector
- Strategic Transition Completed: BiomX Inc. has announced the completion of its strategic transition towards defense, security, and critical infrastructure technologies, aiming to address the growing physical threat landscape and enhance its competitive position in these markets.
- Updated Technology Portfolio: The company's current technology portfolio includes the AI-powered Autonomous Command Center platform Zorronet and laser-based threat detection technology DFSL, designed to improve the speed of identifying and responding to physical threats, meeting the urgent market demand for security technologies.
- Strengthened Leadership Team: BiomX's leadership and advisory team possesses extensive experience in defense technology and public markets, enhancing the company's ability to evaluate, acquire, and advance new technologies to address evolving security needs.
- Compliance Plan Implementation: The company is focused on implementing its NYSE American compliance plan, aiming to build a stronger financial and operational foundation over time to support long-term growth and market competitiveness.
See More
BiomX Receives Approval for NYSE Compliance Plan
- Compliance Plan Approval: BiomX received notification from NYSE on June 10, 2026, confirming acceptance of its compliance plan, which is set to last until September 25, 2027, aimed at regaining compliance with NYSE listing standards and ensuring continued trading of its stock on NYSE American.
- Financial Warning: The company reported a stockholders' equity deficit of $1.302 million as of December 31, 2025, alongside ongoing losses over the past five fiscal years, prompting NYSE to require corrective actions for compliance restoration.
- Periodic Review Mechanism: During the implementation of the compliance plan, NYSE will conduct periodic reviews of BiomX's compliance, which not only tests the company's management capabilities but also impacts its future market performance and investor confidence.
- Business Operations Unaffected: Despite facing compliance challenges, BiomX stated that its business operations and reporting obligations to the SEC will remain unaffected, indicating that the company will maintain normal operations while addressing compliance issues.
See More
BiomX Unveils New Insights on Security Industry
- Industry Transformation: BiomX's Zorronet CEO Idan Wasserman emphasizes in a new review that the future of AI security systems will hinge not on the number of surveillance devices but on their ability to understand information, thereby enhancing responses to complex security environments.
- Cultural Context Understanding: The review highlights that AI systems must grasp cultural and situational contexts to accurately assess the significance of behaviors, preventing misjudgments and ensuring security teams can swiftly respond to genuine threats, thus improving overall security efficiency.
- Increased Control Room Burden: As information sources diversify, traditional control rooms are under growing pressure; Wasserman argues that next-generation security platforms must support real-time prioritization and decision-making to tackle complex security challenges effectively.
- Innovative Technology Integration: Zorronet is developing an Autonomous Command Center designed to unify cameras, sensors, drones, and AI agents into a cohesive real-time operational picture, thereby enhancing the speed and coordination of responses for security and operations teams.
See More
BiomX Appoints Prof. Gabby Sarusi as Strategic Advisor
- Strategic Advisor Appointment: BiomX has appointed Prof. Gabby Sarusi as a Strategic Advisor, leveraging his extensive experience in technology development and strategic planning to enhance the company's expansion in defense and security sectors, thereby improving its market competitiveness.
- Industry Background: Prof. Sarusi brings 17 years of senior leadership experience from Elbit Systems Electro-Optics, where he was involved in developing technologies such as satellite cameras and infrared detectors, providing valuable industry insights for BiomX's integration in critical infrastructure and first-response sectors.
- Market Alignment: Prof. Sarusi noted that the defense and security market is moving towards earlier threat detection and faster response capabilities, aligning perfectly with BiomX's technologies, which are expected to enhance the company's ability to address emerging threats effectively.
- Academic and Practical Integration: With dual bachelor's degrees in Nuclear Engineering and Materials Engineering, along with a master's and Ph.D. in Electrical Engineering, and research experience at NASA and AT&T Bell Labs, Prof. Sarusi's academic background will strongly support BiomX's technological innovation and market application.
See More
BiomX to Acquire 60% Stake in Tsoock for $10.4M
- Acquisition Intent: BiomX announced a non-binding letter of intent to acquire a 60% controlling interest in Tsoock Defense Technologies for $10.4 million, aiming to enhance its market position in defense and critical infrastructure sectors.
- Payment Structure: The deal includes an initial payment of $300,000, with the remaining $10.1 million to be paid in four quarterly installments over 12 months, which helps alleviate immediate financial pressure.
- Strategic Importance: Upon completion, the acquisition is expected to add a secure-site execution and systems integration layer to BiomX's growing defense, security, and first-response portfolio, enhancing its ability to apply technologies in real-world operational environments.
- Future Acquisition Option: The letter of intent also includes an option for BiomX to acquire the remaining 40% of Tsoock for $9.2 million within 36 months post-transaction, providing flexibility and strategic opportunities for future expansion.
See More
BiomX Advances AI Systems with Israel Railways Collaboration
- Implementation of Cooperation Agreement: BiomX's wholly-owned subsidiary Zorronet has commenced the installation of AI and ML-powered detection systems on sections of the Israel Railways network, aimed at protecting wildlife and maintaining national infrastructure, with the initial phase covering four segments and plans for further expansion.
- Significant Success Rate: The large-scale pilot conducted over the past year achieved a 98% success rate in keeping large animals off the railway tracks, with zero related collisions during that period, underscoring its importance in safety management.
- Strong Technological Adaptability: The system integrates multiple data sources to detect human and animal approaches to the tracks, triggering alerts and automated responses based on risk assessments, fully meeting the operational requirements of Israel Railways.
- Infrastructure Expansion Opportunities: The opening of a new eastern line by Israel Railways this week further expands the national rail network, creating potential opportunities for future deployments and deeper collaboration, enhancing BiomX's strategic position in infrastructure safety.
See More
BiomX Completes Strategic Transition to Defense Sector
- Strategic Transition Completed: BiomX Inc. has announced the completion of its strategic transition towards defense, security, and critical infrastructure technologies, aiming to address the growing physical threat landscape and enhance its competitive position in these markets.
- Updated Technology Portfolio: The company's current technology portfolio includes the AI-powered Autonomous Command Center platform Zorronet and laser-based threat detection technology DFSL, designed to improve the speed of identifying and responding to physical threats, meeting the urgent market demand for security technologies.
- Strengthened Leadership Team: BiomX's leadership and advisory team possesses extensive experience in defense technology and public markets, enhancing the company's ability to evaluate, acquire, and advance new technologies to address evolving security needs.
- Compliance Plan Implementation: The company is focused on implementing its NYSE American compliance plan, aiming to build a stronger financial and operational foundation over time to support long-term growth and market competitiveness.
See More
BiomX Receives Approval for NYSE Compliance Plan
- Compliance Plan Approval: BiomX received notification from NYSE on June 10, 2026, confirming acceptance of its compliance plan, which is set to last until September 25, 2027, aimed at regaining compliance with NYSE listing standards and ensuring continued trading of its stock on NYSE American.
- Financial Warning: The company reported a stockholders' equity deficit of $1.302 million as of December 31, 2025, alongside ongoing losses over the past five fiscal years, prompting NYSE to require corrective actions for compliance restoration.
- Periodic Review Mechanism: During the implementation of the compliance plan, NYSE will conduct periodic reviews of BiomX's compliance, which not only tests the company's management capabilities but also impacts its future market performance and investor confidence.
- Business Operations Unaffected: Despite facing compliance challenges, BiomX stated that its business operations and reporting obligations to the SEC will remain unaffected, indicating that the company will maintain normal operations while addressing compliance issues.
See More
BiomX Unveils New Insights on Security Industry
- Industry Transformation: BiomX's Zorronet CEO Idan Wasserman emphasizes in a new review that the future of AI security systems will hinge not on the number of surveillance devices but on their ability to understand information, thereby enhancing responses to complex security environments.
- Cultural Context Understanding: The review highlights that AI systems must grasp cultural and situational contexts to accurately assess the significance of behaviors, preventing misjudgments and ensuring security teams can swiftly respond to genuine threats, thus improving overall security efficiency.
- Increased Control Room Burden: As information sources diversify, traditional control rooms are under growing pressure; Wasserman argues that next-generation security platforms must support real-time prioritization and decision-making to tackle complex security challenges effectively.
- Innovative Technology Integration: Zorronet is developing an Autonomous Command Center designed to unify cameras, sensors, drones, and AI agents into a cohesive real-time operational picture, thereby enhancing the speed and coordination of responses for security and operations teams.
See More
BiomX Appoints Prof. Gabby Sarusi as Strategic Advisor
- Strategic Advisor Appointment: BiomX has appointed Prof. Gabby Sarusi as a Strategic Advisor, leveraging his extensive experience in technology development and strategic planning to enhance the company's expansion in defense and security sectors, thereby improving its market competitiveness.
- Industry Background: Prof. Sarusi brings 17 years of senior leadership experience from Elbit Systems Electro-Optics, where he was involved in developing technologies such as satellite cameras and infrared detectors, providing valuable industry insights for BiomX's integration in critical infrastructure and first-response sectors.
- Market Alignment: Prof. Sarusi noted that the defense and security market is moving towards earlier threat detection and faster response capabilities, aligning perfectly with BiomX's technologies, which are expected to enhance the company's ability to address emerging threats effectively.
- Academic and Practical Integration: With dual bachelor's degrees in Nuclear Engineering and Materials Engineering, along with a master's and Ph.D. in Electrical Engineering, and research experience at NASA and AT&T Bell Labs, Prof. Sarusi's academic background will strongly support BiomX's technological innovation and market application.
See More
